During treatment, GLP-1RAs show a neutral risk compared with DPP4is and a lower risk compared with SGLT2is
Phase 3 trials (the TRIUMPH programme, registered on ClinicalTrials.gov) are currently underway, evaluating retatrutide across broader populations including those with cardiovascular disease, type 2 diabetes, and obesity-related complications
Ultra-Mild Formula for All Scalp & Hair Types Free of sulfate, parabens, harsh alcohol, and artificial irritating fragrances, the whole set features a mild and low-stimulus formula
There was a slightly higher rate of gallbladder disorders in the semaglutide group (2.8% vs
Uptake of generic weight-loss drugs will depend on local regulatory approvals, product quality and clinical guidelines, as well as physician confidence in specific products
With the right approach, pores can be visibly reduced